International Journal of Epidemiology 2000;29:362-368
© International Epidemiological Association 2000
Ten years of serological surveillance in England and Wales: methods, results, implications and action
a PHLS Sero-Epidemiology Unit, Immunisation Division, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK.
b PHLS Sero-Epidemiology Unit, Preston Public Health Laboratory, Royal Preston Hospital, PO Box 202, Sharoe Green Lane, Fulwood, Preston, Lancashire PR2 9HG, UK.
c PHLS Sero-Epidemiology Unit, Public Health Laboratory Service North West, Directorate Office, Vicarage Lane, Fulwood, Preston, Lancashire PR2 8DW, UK.
Background The first age-stratified serological survey of antibody to measles, mumps and rubella in the UK was conducted in 1986/87 prior to the introduction of MMR vaccine into the immunization programme. Serum collection and testing have continued annually, allowing trends over time to be monitored. These sera have also been available for ad hoc surveys of other infections.
Methods Residual sera are collected in participating laboratories and sent to a central store where they are irrevocably unlinked from identifying data. A unique identity number is assigned to each serum and details of age and sex are collated on a database. The sera are accessed for testing as required.
Results The results of recurring and other surveys performed over the last ten years are presented. These demonstrate that opportunistic serum samples are an ideal resource for serological surveillance programmes.
Conclusions The serological surveillance programme has provided past exposure profiles for many infections. These data have resulted in a number of national policy changes and have been instrumental in shaping the UK vaccination programme.
Keywords Serological surveillance, immunization, vaccine preventable diseases, mathematical modelling, MMR
Accepted 27 August 1999
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Balmer, R. Borrow, J. Findlow, R. Warrington, S. Frankland, P. Waight, R. George, N. Andrews, and E. Miller Age-Stratified Prevalences of Pneumococcal-Serotype-Specific Immunoglobulin G in England and Their Relationship to the Serotype-Specific Incidence of Invasive Pneumococcal Disease Prior to the Introduction of the Pneumococcal 7-Valent Conjugate Vaccine Clin. Vaccine Immunol., November 1, 2007; 14(11): 1442 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Trotter, J. Findlow, P. Balmer, A. Holland, R. Barchha, N. Hamer, N. Andrews, E. Miller, and R. Borrow Seroprevalence of Bactericidal and Anti-Outer Membrane Vesicle Antibodies to Neisseria meningitidis Group B in England Clin. Vaccine Immunol., July 1, 2007; 14(7): 863 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bellaby Has the UK government lost the battle over MMR? BMJ, March 12, 2005; 330(7491): 552 - 553. [Full Text] [PDF]
|
|
|
|
|
|
J. McVernon, C. L Trotter, M. P E Slack, and M. E Ramsay Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study BMJ, September 18, 2004; 329(7467): 655 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Morris-Cunnington, W. J. Edmunds, E. Miller, and D. W. G. Brown A Population-based Seroprevalence Study of Hepatitis A Virus Using Oral Fluid in England and Wales Am. J. Epidemiol., April 15, 2004; 159(8): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Vyse, N. J. Gay, J. M. White, M. E. Ramsay, D. W. G. Brown, B. J. Cohen, L. M. Hesketh, P. Morgan-Capner, and E. Miller Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence-based Vaccination Policy Epidemiol. Rev., December 1, 2002; 24(2): 125 - 136. [Full Text] [PDF]
|
|